If you’ve been taking Zantac for a while, you might have noticed that the pill has started to show some negative side effects. One such issue is the risk of esophageal cancer. Another one is the risk of pancreatic cancer. There are also a couple of other issues that people might not be aware of, such as the possibility that Zantac may cause kidney problems.
NDMA causes cancer
A Zantac lawsuit claims that the makers of the heartburn medication knew the drug was contaminated with a cancer-causing substance. According to the plaintiffs, the makers of Zantac did not warn the public that the drug was contaminated with NDMA, a probable human carcinogen.
NDMA is a chemical that can cause liver damage, nervous system disorders, and arrhythmia. In addition, it is a suspected carcinogen for both humans and animals.
The Food and Drug Administration (FDA) has determined that the cancer-causing substance N-Nitrosodimethylamine (NDMA) has been found in several batches of ranitidine drugs. FDA testing indicates that NDMA impurities are more prevalent in products that are stored for a longer period of time.
As a result, the FDA recalled many of the products in April 2020. It advised consumers to stop using Zantac. Other NDMA-contaminated medications include blood pressure medicines, heart failure medications, and ulcer-treatment drugs.
There have been a large number of lawsuits filed against these medicines for causing cancer. However, some studies have shown no increase in the risk of cancer when a person uses them.
NDMA causes bladder cancer
NDMA is a member of the N-nitrosamine family of carcinogenic compounds. Its toxic effects include liver, kidney, and lung cancer.
There are a variety of ways to be exposed to NDMA. One source of exposure is through the use of antacid medications. Another is through consumer products such as cigarettes. People may also be exposed to NDMA through environmental sources such as soil, water, and air.
The Food and Drug Administration advises that no more than 0.096 micrograms of NDMA can be ingested per day. This amount is considered a safe limit, but the actual amount of NDMA in food and water can be higher.
Animal studies have shown that NDMA increases the risk of certain types of cancer. It is especially harmful to the liver. Moreover, high levels of NDMA can cause internal bleeding.
NDMA has been found in drugs, including those based on ranitidine. In June 2019, the FDA reported that several ranitidine-based medicines tested positive for N-Nitrosodimethylamine. These drugs are being withdrawn from the market.
NDMA causes pancreatic cancer
Pancreatic cancer is one of the most common forms of cancer in the United States. It is often detected late in its development and usually results in a poor prognosis. Symptoms of pancreatic cancer include jaundice and weight loss.
N-nitrosodimethylamine (NDMA), a semi-volatile organic compound, is a potential human carcinogen. This contaminant has been identified in several types of food, including contaminated water, processed foods, and contaminated soil. NDMA is also found in certain occupational settings.
There is limited evidence linking NDMA exposure with gastrointestinal cancer. However, there is a strong correlation between NDMA exposure and colorectal cancer. Several studies have been performed in this area, but the evidence is inconsistent.
One study in the United States examined the relationship between NDMA and liver and gallbladder cancer. The researchers found that NDMA was associated with these two types of cancer, but no other type of cancer. Another study evaluated NDMA and chronic pancreatitis.
NDMA causes esophageal cancer
NDMA, or N-nitrosodimethylamine, is a semi-volatile organic compound that forms naturally and is released into air, soil, and water. It is a potent carcinogen in laboratory animals and is considered a probable human carcinogen.
NDMA is present in food, in certain medications, and in the environment. The Food and Drug Administration has warned consumers about potential risks.
Several studies have found links between NDMA exposure and the risk of cancer. In animal studies, NDMA caused liver cancer and lung cancer.
However, more long-term research is needed to determine the extent of these effects. For now, the CDC recommends avoiding foods containing NDMA and drinking water that may contain NDMA.
A number of blood pressure drugs in the ARB class have been recalled because of their NDMA contamination. These include valsartan, which is used to treat high blood pressure.
In January 2020, the manufacturer of nizatidine, Mylan, recalled the drug. Manufacturers have also been sued in the past for linking their drugs to esophageal and bladder cancers.